BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18695700)

  • 1. The effect of thiazolidinediones on BMD and osteoporosis.
    McDonough AK; Rosenthal RS; Cao X; Saag KG
    Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):507-13. PubMed ID: 18695700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of thiazolidinediones on bone loss and fracture.
    Murphy CE; Rodgers PT
    Ann Pharmacother; 2007 Dec; 41(12):2014-8. PubMed ID: 17940125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thiazolidinediones and skeletal health].
    Meier C; Bodmer M; Meier CR; Kraenzlin ME
    Rev Med Suisse; 2009 Jun; 5(207):1309-10, 1312-3. PubMed ID: 19626930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes and skeletal health.
    Yaturu S
    J Diabetes; 2009 Dec; 1(4):246-54. PubMed ID: 20923525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis.
    Sorocéanu MA; Miao D; Bai XY; Su H; Goltzman D; Karaplis AC
    J Endocrinol; 2004 Oct; 183(1):203-16. PubMed ID: 15525588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolidinedione-induced skeletal fragility--mechanisms and implications.
    Grey A
    Diabetes Obes Metab; 2009 Apr; 11(4):275-84. PubMed ID: 18671797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone metabolism in type 2 diabetes and role of thiazolidinediones.
    Vestergaard P
    Curr Opin Endocrinol Diabetes Obes; 2009 Apr; 16(2):125-31. PubMed ID: 19300092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rosiglitazone on bone mineral density and remodelling parameters in Postmenopausal diabetic women: a 2-year follow-up study.
    Berberoglu Z; Yazici AC; Demirag NG
    Clin Endocrinol (Oxf); 2010 Sep; 73(3):305-12. PubMed ID: 20148906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of thiazolidinediones and fracture risk.
    Meier C; Kraenzlin ME; Bodmer M; Jick SS; Jick H; Meier CR
    Arch Intern Med; 2008 Apr; 168(8):820-5. PubMed ID: 18443256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone as a target of type 2 diabetes treatment.
    Lecka-Czernik B
    Curr Opin Investig Drugs; 2009 Oct; 10(10):1085-90. PubMed ID: 19777397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes and bone health: the relationship between diabetes and osteoporosis-associated fractures.
    Kurra S; Siris E
    Diabetes Metab Res Rev; 2011 Jul; 27(5):430-5. PubMed ID: 21432981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Overview: derangement of bone metabolism in diabetes mellitus].
    Takeuchi Y
    Clin Calcium; 2009 Sep; 19(9):1247-55. PubMed ID: 19721195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinediones and fracture risk in patients with Type 2 diabetes.
    Betteridge DJ
    Diabet Med; 2011 Jul; 28(7):759-71. PubMed ID: 21672000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do thiazolidinediones harm skeletal integrity?].
    Takeuchi Y
    Clin Calcium; 2008 May; 18(5):650-5. PubMed ID: 18445884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of glycemic control, water retention, and musculoskeletal effects of balaglitazone and pioglitazone in diet-induced obese rats.
    Henriksen K; Byrjalsen I; Nielsen RH; Madsen AN; Larsen LK; Christiansen C; Beck-Nielsen H; Karsdal MA
    Eur J Pharmacol; 2009 Aug; 616(1-3):340-5. PubMed ID: 19595686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials.
    Zhu ZN; Jiang YF; Ding T
    Bone; 2014 Nov; 68():115-23. PubMed ID: 25173606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis risk in premenopausal women.
    Vondracek SF; Hansen LB; McDermott MT
    Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
    Krentz A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):112-26. PubMed ID: 19219860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetes mellitus, antidiabetics and bone].
    Svacina S
    Cas Lek Cesk; 2010; 149(6):282-4. PubMed ID: 20662475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mass measurement and factors associated with risk of fracture in a group of peri- and postmenoupausal women.
    Rasheed A; Khurshid R; Aftab L
    J Ayub Med Coll Abbottabad; 2008; 20(1):48-51. PubMed ID: 19024185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.